• $92.1M
    Market Cap
  • 1.45%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
40.4M
+6.68%
37.9M
-4.26%
39.6M
-5.85%
42.0M
+16.75%
Cost of Revenue
6.7M
+1.23%
6.6M
+8.56%
6.1M
-33.47%
9.1M
+3.49%
Gross Profit
33.7M
+7.82%
31.3M
-6.58%
33.5M
+1.80%
32.9M
+21.04%
Sales and Marketing Expense
19.1M
+12.19%
17.0M
-7.74%
18.5M
+10.75%
16.7M
+10.96%
Research and Development Expense
-5.6M
+15.58%
-4.8M
-17.45%
-5.8M
-12.78%
-6.7M
+17.67%
Depreciation and Amortization Expense
4.1M
-15.45%
4.9M
-0.68%
4.9M
-7.36%
5.3M
+15.67%
Total Operating Expenses
47.3M
+6.80%
44.3M
-9.79%
49.1M
+2.92%
47.7M
+9.28%
Operating Profit
-2.8M
-56.59%
-6.4M
-32.68%
-9.6M
+67.48%
-5.7M
-25.69%
Interest Income
476,748
+42.55%
334,444
+16.59%
286,854
+191.50%
98,405
+277.31%
Interest Expense
-495,990
-18.09%
-605,508
-9.34%
-667,861
+13.97%
-585,995
+497.76%
Interest Income and Expense and Net
-19,242
-92.90%
-271,064
-28.86%
-381,007
-21.86%
-487,590
+577.68%
Total Nonoperating Income and Expense
495,990
-18.09%
605,508
-9.34%
667,861
+13.97%
585,995
+497.76%
Income before Taxes
-2.8M
-56.53%
-6.5M
+2.89%
-6.3M
+12.61%
-5.6M
+0.34%
Income Taxes
40,256
+277.58%
-22,669
-149.53%
45,769
-33.52%
68,850
+97.33%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-2.8M
-56.23%
-6.5M
+3.19%
-6.3M
+12.73%
-5.6M
+58.81%
Net Income from Continuing Operations Applicable to Common
-2.8M
-56.14%
-6.5M
+2.89%
-6.3M
+12.61%
-5.6M
+0.34%
Basic EPS and Net Income
-0.19
-58.70%
-0.46
+4.55%
-0.44
+15.79%
-0.38
+58.33%
Diluted EPS and Net Income
-0.19
-58.70%
-0.46
+4.55%
-0.44
+15.79%
-0.38
+58.33%
Basic Weighted Average Shares
14.9M
+5.65%
14.1M
-1.67%
14.3M
-1.82%
14.6M
-2.29%
Diluted Weighted Average Shares
14.9M
+5.65%
14.1M
-1.67%
14.3M
-1.82%
14.6M
-2.29%
Balance Sheet
Cash and Cash Equivalents
11.4M
-36.29%
18.0M
-1.95%
18.3M
-7.27%
19.8M
-26.93%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
11.4M
-36.29%
18.0M
-1.95%
18.3M
-7.27%
19.8M
-26.93%
Total Current Assets
37.1M
+1.67%
36.5M
+2.07%
35.7M
-22.14%
45.9M
+0.40%
Accumulated Depreciation
2.5M
+4.62%
2.4M
+6.87%
2.2M
+7.33%
2.1M
-45.01%
Property and Plant and Equipment and Net
264,724
-4.56%
277,365
-24.61%
367,903
+29.53%
284,039
-35.83%
Total Long-Term Assets
3.0M
+6.80%
2.8M
+3.38%
2.7M
+6.83%
2.5M
-26.29%
Total Assets
76.8M
+1.64%
75.6M
-7.57%
81.8M
-12.00%
92.9M
+10.02%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
0
-100.00%
5.1M
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
36.7M
+16.20%
31.6M
+13.01%
28.0M
-2.09%
28.6M
+48.24%
Total Long-Term Debt
5.2M
-48.50%
10.2M
-20.40%
12.8M
-21.09%
16.2M
+8.00%
Total Long-Term Liabilities
5.8M
-7.58%
6.3M
-2.38%
6.5M
-14.92%
7.6M
+1.28%
Total Liabilities
52.3M
-1.43%
53.0M
+0.99%
52.5M
-7.79%
57.0M
+36.06%
Retained Earnings
-26.8M
+11.83%
-24.0M
+37.05%
-17.5M
+56.02%
-11.2M
+98.79%
Total Stockholders Equity
24.9M
+8.87%
22.9M
-22.80%
29.6M
-18.37%
36.3M
-15.29%
Total Shares Outstanding
15.0M
+7.20%
14.0M
-1.20%
14.1M
-1.70%
14.4M
-2.55%
Cash Flow
Cash from Operating Activities
4.9M
+905.72%
-612,186
-110.05%
6.1M
-27.91%
8.5M
+33.28%
Capital Expenditures
97,903
+47.31%
66,461
-76.37%
281,268
+175.35%
102,148
-1.34%
Cash from Investing Activities
-4.7M
-8,236.82%
57,842
+154.73%
-105,695
-99.23%
-13.7M
+2,624.58%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-6.7M
-3,525.79%
196,904
+102.65%
-7.4M
+260.10%
-2.1M
-41.98%
Financials Ratio
Gross Margin
83.50%
+1.07%
82.61%
-2.43%
84.66%
+8.13%
78.29%
+3.68%
Operating Margin
-6.91%
-59.31%
-16.99%
-29.68%
-24.16%
+77.89%
-13.58%
-36.35%
Return on Assets
-3.72%
-54.81%
-8.24%
+14.56%
-7.19%
+14.46%
-6.28%
+61.97%
Return on Equity
-11.88%
-51.90%
-24.71%
+29.58%
-19.07%
+35.34%
-14.09%
+80.34%
Revenue Growth
6.68%
+256.76%
-4.26%
-27.22%
-5.85%
-134.95%
16.75%
+530.59%
Current Ratio
1.01
-12.51%
1.15
-9.68%
1.28
-20.48%
1.61
-32.27%
Cash Ratio
0.31
-45.17%
0.57
-13.24%
0.65
-5.28%
0.69
-50.71%
Debt-to-Equity Ratio
0.21
-68.49%
0.67
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.07
-66.25%
0.20
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow